Fonte: Frontiers in pharmacology. Unidade: FM
Assuntos: FÁRMACOS DO SANGUE E SISTEMA HEMATOPOÉTICO, BRASILEIROS, POLIMORFISMO, ANTICOAGULANTES
ABNT
TAVARES, Leticia C. e KRIEGER, Jose E. Association Between ABCB1 Polymorphism and Stable Warfarin Dose Requirements in Brazilian Patients. Frontiers in pharmacology, v. 9, 2018Tradução . . Disponível em: https://doi.org/10.3389/fphar.2018.00542. Acesso em: 02 nov. 2025.APA
Tavares, L. C., & Krieger, J. E. (2018). Association Between ABCB1 Polymorphism and Stable Warfarin Dose Requirements in Brazilian Patients. Frontiers in pharmacology, 9. doi:10.3389/fphar.2018.00542NLM
Tavares LC, Krieger JE. Association Between ABCB1 Polymorphism and Stable Warfarin Dose Requirements in Brazilian Patients [Internet]. Frontiers in pharmacology. 2018 ; 9[citado 2025 nov. 02 ] Available from: https://doi.org/10.3389/fphar.2018.00542Vancouver
Tavares LC, Krieger JE. Association Between ABCB1 Polymorphism and Stable Warfarin Dose Requirements in Brazilian Patients [Internet]. Frontiers in pharmacology. 2018 ; 9[citado 2025 nov. 02 ] Available from: https://doi.org/10.3389/fphar.2018.00542